Alabama study aims to unlock HIV prevention secrets for women
NCT ID NCT05463692
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study follows 830 women in Alabama who are at risk for HIV and sexually transmitted infections (STIs). Researchers will use a smartphone app to provide information and resources, and track how many women start using PrEP, a medication that prevents HIV. The goal is to learn what factors affect STI risk and PrEP use, so better prevention strategies can be developed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal key factors that help prevent HIV and STIs in women, leading to better prevention programs.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly cure or prevent disease. Results depend on participant reporting and may not apply to all women.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Peer support may lift the cloud of loneliness for older gay men with HIV
- Can peer mentors help gay men with HIV stay in care?
- HIV and hidden health risks: a major study probes the link
- Faith-Based therapy aims to heal trauma in young women
- Bringing HIV care to the community: a new test in zambia
- Could intense workouts reverse cognitive decline in older HIV patients?